ALTSTATION.IO

Align Technology, Inc. (ALGN) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$184.20

Change

+4.89%

Market Cap

$13.35B

Avg Volume

1.2M

Company Overview

Align Technology, Inc. is a healthcare company based in Tempe, Arizona, specializing in orthodontic products and services. Its flagship product is the Invisalign clear aligner system, which provides a non-metallic option for treating teeth misalignments in adults and teenagers. They also offer Vivera retainers and the iTero intraoral scanner, which helps dental professionals in restorative and orthodontic procedures. Their products target orthodontists, dentists, and patients looking for effective and aesthetically pleasing dental solutions.

Align is a market leader in the clear aligner segment, holding a significant share of the global market. Its strong position stems from continuous innovation and a well-established brand presence. However, competition from companies like SmileDirectClub and traditional braces manufacturers poses a threat, as do evolving consumer preferences towards more cost-effective solutions. Regulatory challenges and the need for constant technological advancements also impact the competitive landscape.

Currently, Align is experiencing growth driven by increasing demand for clear aligners and advancements in digital dentistry. The company recently expanded its product portfolio with new offerings in the CAD/CAM services segment, boosting its revenue potential. In addition, international expansion efforts are underway, presenting further opportunities. Overall, Align is positioning itself well for continued success, but it must navigate growing competition carefully.

Key Financials

Market Cap

$13.35B

Revenue

$4.03B

EBITDA

$796.80M

Gross Margin

68.0%

Profit Margin

10.2%

Revenue Growth

5.3%

Total Cash

$1.09B

Total Debt

$82.51M

Free Cash Flow

$410.96M

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

32.60

Forward P/E

15.09

Beta

1.83

52-Week High

$224.18

52-Week Low

$122.00

EPS

$5.65

50-Day Avg

$161.57

200-Day Avg

$159.49

Price/Book

3.26

Technical Analysis

Align Technology, Inc. (ALGN) has displayed a bearish overall trend over the 52-week period, showing a significant decline of 11.5% and failing to maintain levels above $200 since July. Key resistance is evident at approximately $220, while support is established around $140, with the price recently testing but not breaking through $187.6 in February. Notably, a descending trend line from July suggests ongoing downward pressure since that peak. In recent weeks, there has been slight bullish momentum, with price recovering from the lows earlier in the year but still below the identified resistance level. Currently, at $184.20, the price sits near the midpoint of its 52-week range, indicating potential indecision among investors as it attempts to reclaim lost ground but remains vulnerable to further declines.

Recent News and Developments

Here’s a summary of the latest news and developments for Align Technology, Inc

(ALGN) stock in the past week, from February 1st to February 7th, 2026:

1. Align Technology Beats Q4 2025 Earnings and Revenue Estimates, Stock Surges

Align Technology reported strong financial results for the fourth quarter of 2025, surpassing analyst expectations for both earnings per share (EPS) and revenue. The company announced an adjusted EPS of $3.29 and revenues of $1.05 billion, exceeding the average analyst estimates of $2.99 per share and $1.03 billion, respectively. Following this positive earnings report on February 5, 2026, ALGN shares climbed by 13%.

2. Analysts Raise Price Targets for ALGN Following Strong Earnings

In the wake of Align Technology’s impressive Q4 2025 earnings, several analyst firms adjusted their outlooks for the company. Stifel raised its price target for ALGN to $210 from $200, citing prudent 2026 guidance and momentum built in the latter half of 2025. Jefferies Financial Group also issued a new price target of $185.00.

Market Sentiment and Analyst Recommendations

Bull Case

ALGN just beat Q4 earnings by 10% on EPS ($3.29 vs $2.99) and cleared revenue estimates by 2%, which triggered a 13% single-day rally. The 3D printing pivot is real differentiation — moving from thermoforming to direct fabrication of Invisalign products in 2026 improves margins and locks in customer switching costs. Stifel raised its target to $210, implying 14% upside from current levels, and the analyst consensus sits at $194, which is essentially flat from here but represents stabilization after the 11.5% decline over 52 weeks. With $1.09B in cash against just $82.51M in debt, the balance sheet is fortress-like and gives management room to invest in manufacturing infrastructure or return capital. The iTero intraoral scanner business is expanding — the University of Bern collaboration shows the device is becoming standard in clinical research, which drives recurring revenue and ecosystem lock-in. At 32.6x P/E, you’re paying for a company that just proved it can beat estimates and execute on hardware transitions most competitors can’t match.

Bear Case

Revenue growth of 5.3% is pedestrian for a company trading at 32.6x earnings — that’s a premium valuation for mid-single-digit top-line expansion. The stock has failed to hold above $200 since July and sits right in the middle of its 52-week range, which tells you the market is unconvinced about the durability of this rally. A 13% one-day pop on earnings is a classic bull trap; the stock is already pricing in execution on the 3D printing roadmap, so any delay or yield issues in manufacturing could crater sentiment quickly. The orthodontics market itself is mature and discretionary — macro weakness hits elective dental procedures hard, and ALGN has no hedge if recession cuts into case volume. Analyst targets range from $150 to $225, a 50% spread, which signals genuine uncertainty about fair value. The descending trendline from July suggests institutional sellers are still in control, and one quarter of beats doesn’t erase the structural weakness that knocked the stock down 11.5% over the past year.

What to Watch

Monitor Q1 2026 guidance in the next earnings call for management’s confidence in 3D printing timelines and whether they’re guiding margins higher as manufacturing ramps. Watch the $200 resistance level closely — if ALGN can’t hold above it after this earnings bounce, the July downtrend is reasserting and the $140 support becomes the real target. Track quarterly case volumes and average selling prices on Invisalign, especially in international markets where growth has lagged; slowing case growth would justify the 5.3% revenue guidance and suggest the bull case is overcooked. The iTero scanner revenue and attach rate need to improve quarter-over-quarter to validate the ecosystem strategy; if it’s still a secondary revenue stream in Q1, the narrative shifts. Watch for any manufacturing delays or yield issues with the 3D printed products when they launch — execution risk is high and the stock is priced for perfection. Finally, keep an eye on the $220 resistance and whether Stifel’s $210 target holds; if the stock rolls over below $180, you’re looking at a failed breakout and potential retest of $140 support.

Analyst Consensus

BUY

Based on 15 analyst opinions

Low Target

$150.00

Mean Target

$194.07

High Target

$225.00

Earnings and Financial Data

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

N/A

Earnings & Dividends

Next Earnings

Apr 29, 2026

EPS (Trailing)

$5.65

Dividend Yield

None

Payout Ratio

Frequently Asked Questions

Is ALGN a good stock to buy?

Yes, analysts recommend ALGN with a target price of $194.07, indicating potential upside from the current price of $184.20. With a forward P/E of 15.09, the stock appears undervalued relative to future earnings.

What is ALGN’s price target?

Analysts have set a price target for ALGN at $194.07. This represents a gain of about 5.3% from the current trading price.

Does ALGN pay a dividend?

No, Align Technology does not offer a dividend. Investors should consider this if they’re looking for income-generating investments, as the company primarily reinvests profits into growth.

What is ALGN’s market cap?

Align Technology has a market cap of $13.35 billion. This positions the company as a significant player in the medical instruments and supplies sector.

What has been ALGN’s stock price range over the last year?

ALGN has traded between $122.00 and $224.18 over the past 52 weeks. This volatility reflects market conditions and investor sentiment toward the company’s growth prospects.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.